A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma
Plasmablastic lymphoma (PBL) and plasmablastic plasma cell myeloma (PCM) have many overlapping characteristics. Clinical correlation can help make the distinction between the two entities. Human immunodeficiency virus- (HIV-) negative PBL is a rare disease, making the diagnosis more challenging. Whi...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2019/2907317 |
id |
doaj-6d612f24a9914276a4153ed7ded0673f |
---|---|
record_format |
Article |
spelling |
doaj-6d612f24a9914276a4153ed7ded0673f2020-11-25T00:02:27ZengHindawi LimitedCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/29073172907317A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic DilemmaAlaina J. Kessler0Bridget K. Marcellino1Scot A. Niglio2Bruce E. Petersen3Adriana K. Malone4Department of Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USATisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USATisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USATisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAPlasmablastic lymphoma (PBL) and plasmablastic plasma cell myeloma (PCM) have many overlapping characteristics. Clinical correlation can help make the distinction between the two entities. Human immunodeficiency virus- (HIV-) negative PBL is a rare disease, making the diagnosis more challenging. While there is no standard of care for PBL, current recommendations include dose-adjusted EPOCH (etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone), with or without bortezomib. We report an aggressive case of HIV-negative plasmablastic lymphoma and discuss the challenge in establishing a diagnosis. We review the literature regarding this disease and current recommendations for treatment.http://dx.doi.org/10.1155/2019/2907317 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alaina J. Kessler Bridget K. Marcellino Scot A. Niglio Bruce E. Petersen Adriana K. Malone |
spellingShingle |
Alaina J. Kessler Bridget K. Marcellino Scot A. Niglio Bruce E. Petersen Adriana K. Malone A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma Case Reports in Hematology |
author_facet |
Alaina J. Kessler Bridget K. Marcellino Scot A. Niglio Bruce E. Petersen Adriana K. Malone |
author_sort |
Alaina J. Kessler |
title |
A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma |
title_short |
A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma |
title_full |
A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma |
title_fullStr |
A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma |
title_full_unstemmed |
A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma |
title_sort |
rare presentation of hiv-negative plasmablastic lymphoma: a diagnostic dilemma |
publisher |
Hindawi Limited |
series |
Case Reports in Hematology |
issn |
2090-6560 2090-6579 |
publishDate |
2019-01-01 |
description |
Plasmablastic lymphoma (PBL) and plasmablastic plasma cell myeloma (PCM) have many overlapping characteristics. Clinical correlation can help make the distinction between the two entities. Human immunodeficiency virus- (HIV-) negative PBL is a rare disease, making the diagnosis more challenging. While there is no standard of care for PBL, current recommendations include dose-adjusted EPOCH (etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone), with or without bortezomib. We report an aggressive case of HIV-negative plasmablastic lymphoma and discuss the challenge in establishing a diagnosis. We review the literature regarding this disease and current recommendations for treatment. |
url |
http://dx.doi.org/10.1155/2019/2907317 |
work_keys_str_mv |
AT alainajkessler ararepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT bridgetkmarcellino ararepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT scotaniglio ararepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT bruceepetersen ararepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT adrianakmalone ararepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT alainajkessler rarepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT bridgetkmarcellino rarepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT scotaniglio rarepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT bruceepetersen rarepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma AT adrianakmalone rarepresentationofhivnegativeplasmablasticlymphomaadiagnosticdilemma |
_version_ |
1725437636400644096 |